Elixxer Ltd.
ELIXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.19M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.19 Million |
|---|---|
| Enterprise Value | $13.69 Million |
| Earnings per Share | $-0.34 |
| Beta | -0.54 |
| Outstanding Shares | 67,439,000 |
Return
| Return on Equity | 31.51% |
|---|---|
| Return on Assets | -331.68% |
| Return on Invested Capital | 8.25% |
Valuation & Multiples
| P/E Ratio | -0.19 |
|---|---|
| PEG | 0.42 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -15.45 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.77 |
| Debt to Equity | -0.98 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 26, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Elixxer Ltd.
0CEO: Karim Mecklai
Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specia...